Early and late responders did not differ in respect to sex, age at diagnosis, impaired glucose metabolism (diabetes, impaired fasting glucose or glucose tolerance), GH and IGF1 levels at diagnosis or before pasireotide treatment and tumour volume at diagnosis. The gene discussed is IGF1; the disease is diabetes mellitus.